We report unique intrinsic alterations of MSCs from SSc patients in their response to key-mediators (CTGF, b-FGF, PDGF-BB, and TGF-β1) of SSc related vasculopathy and fibrosis. The gene discussed is FGF2; the disease is systemic sclerosis.